全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

胃肠道癌患者经济毒性影响因素及应对策略的研究进展
Research Progress on Factors Influencing Economic Toxicity and Coping Strategies in Patients with Gastrointestinal Cancer

DOI: 10.12677/ns.2024.139171, PP. 1211-1218

Keywords: 胃肠道癌,经济毒性,影响因素,综述
Gastrointestinal Cancer
, Economic Toxicity, Influencing Factors, Review

Full-Text   Cite this paper   Add to My Lib

Abstract:

随着新兴医疗技术发展应用,癌症患者存活率有所提高,随之而来的是高昂的治疗成本,严重影响癌症患者身心健康。从胃肠道癌患者经济毒性的概念、现状、评估工具、影响因素以及应对策略等方面进行综述,以期增强临床工作者对癌症患者经济毒性风险评估能力,为建立胃肠道癌患者经济毒性预警模型和实施护理干预措施提供参考。
With the development and application of emerging medical technologies, the survival rate of cancer patients has been improved, and consequently, the treatment cost is high, which seriously affects the physical and mental health of cancer patients. The concept, current situation, assessment tools, influencing factors and coping strategies of economic toxicity in gastrointestinal cancer patients are reviewed in order to enhance the ability of clinical workers to assess the risk of economic toxicity in cancer patients, and to provide reference for the establishment of an early warning model of economic toxicity in patients with gastrointestinal cancer and the implementation of nursing interventions.

References

[1]  Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263.
https://doi.org/10.3322/caac.21834
[2]  Anwanwan, D., Singh, S.K., Singh, S., Saikam, V. and Singh, R. (2020) Challenges in Liver Cancer and Possible Treatment Approaches. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1873, Article 188314.
https://doi.org/10.1016/j.bbcan.2019.188314
[3]  Zhang, K., Yin, J., Huang, H., Wang, L., Guo, L., Shi, J., et al. (2020) Expenditure and Financial Burden for Stomach Cancer Diagnosis and Treatment in China: A Multicenter Study. Frontiers in Public Health, 8, Article 310.
https://doi.org/10.3389/fpubh.2020.00310
[4]  Lei, H., Lei, L., Shi, J., Wu, Y., Liang, L., Huang, H., et al. (2020) No Expenditure Difference among Patients with Liver Cancer at Stage I-IV: Findings from a Multicenter Cross-Sectional Study in China. Chinese Journal of Cancer Research, 32, 516-529.
https://doi.org/10.21147/j.issn.1000-9604.2020.04.09
[5]  Shi, J., Wang, L., Ran, J., Wang, H., Liu, C., Zhang, H., et al. (2021) Clinical Characteristics, Medical Service Utilization, and Expenditure for Colorectal Cancer in China, 2005 to 2014: Overall Design and Results from a Multicenter Retrospective Epidemiologic Survey. Cancer, 127, 1880-1893.
https://doi.org/10.1002/cncr.33445
[6]  Zafar, S.Y., Peppercorn, J.M., Schrag, D., Taylor, D.H., Goetzinger, A.M., Zhong, X., et al. (2013) The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient’s Experience. The Oncologist, 18, 381-390.
https://doi.org/10.1634/theoncologist.2012-0279
[7]  Bullock, A.J., Hofstatter, E.W., Yushak, M.L. and Buss, M.K. (2012) Understanding Patients’ Attitudes toward Communication about the Cost of Cancer Care. Journal of Oncology Practice, 8, e50-e58.
https://doi.org/10.1200/jop.2011.000418
[8]  Zafar, S.Y. and Abernethy, A.P. (2013) Financial Toxicity, Part I: A New Name for a Growing Problem. Oncology, 27, 80-149.
[9]  况艺, 孙艳玲, 荆凤, 等. 癌症相关经济毒性概念分析[J]. 护理研究, 2021, 35(20): 3695-3700.
[10]  Han, X., Zhao, J., Zheng, Z., de Moor, J.S., Virgo, K.S. and Yabroff, K.R. (2020) Medical Financial Hardship Intensity and Financial Sacrifice Associated with Cancer in the United States. Cancer Epidemiology, Biomarkers & Prevention, 29, 308-317.
https://doi.org/10.1158/1055-9965.epi-19-0460
[11]  Smith, G.L., Lopez-Olivo, M.A., Advani, P.G., Ning, M.S., Geng, Y., Giordano, S.H., et al. (2019) Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes. Journal of the National Comprehensive Cancer Network, 17, 1184-1192.
https://doi.org/10.6004/jnccn.2019.7305
[12]  刘丽, 苏明珠, 张锦欣, 等. 中国恶性肿瘤患者经济毒性发生率的Meta分析: 基于患者报告经济毒性综合评分量表[J]. 中国循证医学杂志, 2023, 23(11): 1269-1274.
[13]  Shao, M., Yao, L., Zhang, M., Zhou, H., Ding, Y., Bai, L., et al. (2024) Post-Surgery Financial Toxicity and Its Influencing Factors in Colorectal Cancer Care: A Cross-Sectional Study. European Journal of Oncology Nursing, 68, Article 102518.
https://doi.org/10.1016/j.ejon.2024.102518
[14]  许可, 张楠, 刘金辉, 等. 肺癌患者经济毒性及影响因素分析[J]. 中华肿瘤防治杂志, 2021, 28(20): 1578-1582.
[15]  阮君怡, 刘城, 况艺, 等. 年轻女性乳腺癌生存者经济毒性应对策略的质性研究[J]. 军事护理, 2022, 39(8): 29-33.
[16]  Khera, N. (2014) Reporting and Grading Financial Toxicity. Journal of Clinical Oncology, 32, 3337-3338.
https://doi.org/10.1200/jco.2014.57.8740
[17]  de Souza, J.A., Yap, B.J., Hlubocky, F.J., Wroblewski, K., Ratain, M.J., Cella, D., et al. (2014) The Development of a Financial Toxicity Patient‐Reported Outcome in Cancer: The COST Measure. Cancer, 120, 3245-3253.
https://doi.org/10.1002/cncr.28814
[18]  于慧会, 毕雪, 刘运泳. 中文版癌症患者报告结局的经济毒性量表信度和效度研究[J]. 中华流行病学杂志, 2017, 38(8): 1118-1120.
[19]  Jazieh, A., Jradi, H., Da’ar, O.B., Alkaiyat, M., Zafar, Y. and Alolayan, A. (2021) Developing, Implementing, and Validating a Social Toxicity Assessment Tool of Cancer. JCO Global Oncology, 7, 1522-1528.
https://doi.org/10.1200/go.21.00170
[20]  Prawitz, A.D., Garman, E.T., Benoit, S., et al. (2006) InCharge Financial Distress/Financial Well-Being Scale: Development, Administration, and Score Interpretation. Journal of Financial Counseling and Planning, 17, 34-50.
https://doi.org/10.1037/t60365-000
[21]  Marshall, G.N. and Hays, R.D. (1994) The Patient Satisfaction Questionnaire Short Form (PSQ-18). RAND Corporation, Santa Monica.
[22]  董奥, 姜玲, 王静, 等. 癌症化疗患者经济毒性水平及影响因素分析[J]. 上海护理, 2022, 22(5): 27-31.
[23]  吕扬, 刘欣哲, 王诺筱萱, 等. 食管癌患者经济毒性体验及应对措施的质性研究[J]. 护理学杂志, 2023, 38(5): 29-33.
[24]  Larsen, I.K., Myklebust, T.Å., Babigumira, R., Vinberg, E., Møller, B. and Ursin, G. (2020) Education, Income and Risk of Cancer: Results from a Norwegian Registry-Based Study. Acta Oncologica, 59, 1300-1307.
https://doi.org/10.1080/0284186x.2020.1817548
[25]  程珂, 曹希, 黎燕红, 等. 结直肠癌患者经济毒性的危险因素分析[J]. 中华肿瘤防治杂志, 2023, 30(16): 984-989.
[26]  孙艳玲, 况艺, 袁潇逸, 等. 癌症生存者经济毒性现状及影响因素[J]. 护理学杂志, 2022, 37(15): 24-27, 31.
[27]  查荣苹, 刘淑华, 曾梦婷, 等. 结直肠癌患者经济毒性现状及影响因素调查分析[J]. 护理学杂志, 2023, 38(10): 70-74.
[28]  吕扬, 朱清淼, 刘畅, 等. 食管癌病人经济毒性现状及影响因素研究[J]. 循证护理, 2023, 9(12): 2181-2186.
[29]  Ramaswamy, A., Babu, V., Kothari, R., Abhinav, R., Desouza, A., Ventrapati, P., et al. (2022) Treatment of Metastatic Colorectal Cancers in Resource-Constrained Low-and Middle-Income Countries (LMICS) Scenario—Outcomes, Practice Patterns, and Commentary on Treatment Costs. South Asian Journal of Cancer, 11, 293-298.
https://doi.org/10.1055/s-0041-1736203
[30]  姜男, 白锦兵, 魏思琪, 等. 癌症患者经济毒性的影响因素及管理策略研究进展[J]. 解放军护理杂志, 2020, 37(9): 62-64.
[31]  Thom, B. and Benedict, C. (2019) The Impact of Financial Toxicity on Psychological Well-Being, Coping Self-Efficacy, and Cost-Coping Behaviors in Young Adults with Cancer. Journal of Adolescent and Young Adult Oncology, 8, 236-242.
https://doi.org/10.1089/jayao.2018.0143
[32]  Kircher, S., Duan, F., An, N., Gareen, I.F., Sicks, J.D., Sadigh, G., et al. (2024) Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer. JAMA Network Open, 7, e2350844.
https://doi.org/10.1001/jamanetworkopen.2023.50844
[33]  杜宽, 胡轶然, 刘源. 我国长期护理保险制度发展现状与思考——基于成都和上海试点城市政策的比较分析[J]. 卫生软科学, 2024, 38(4): 82-87.
[34]  中华人民共和国国家卫生健康委员会医疗应急司. 健康中国行动——癌症防治行动实施方案(2023-2030年) [J]. 中国肿瘤, 2023, 32(12): 887-890.
[35]  Knight, T.G., Aguiar, M., Robinson, M., Morse, A., Chen, T., Bose, R., et al. (2022) Financial Toxicity Intervention Improves Outcomes in Patients with Hematologic Malignancy. JCO Oncology Practice, 18, e1494-e1504.
https://doi.org/10.1200/op.22.00056
[36]  Smith, G.L., Banegas, M.P., Acquati, C., Chang, S., Chino, F., Conti, R.M., et al. (2022) Navigating Financial Toxicity in Patients with Cancer: A Multidisciplinary Management Approach. CA: A Cancer Journal for Clinicians, 72, 437-453.
https://doi.org/10.3322/caac.21730
[37]  American Society of Clinical Oncology (2018) American Society of Clinical Oncology Position Statement on Addressing the Affordability of Cancer Drugs. Journal of Oncology Practice, 14, 187-192.
https://doi.org/10.1200/jop.2017.027359
[38]  Shih, Y.T. and Chien, C. (2016) A Review of Cost Communication in Oncology: Patient Attitude, Provider Acceptance, and Outcome Assessment. Cancer, 123, 928-939.
https://doi.org/10.1002/cncr.30423
[39]  Sadigh, G., Coleman, D., Switchenko, J.M., Hopkins, J.O. and Carlos, R.C. (2022) Treatment Out-of-Pocket Cost Communication and Remote Financial Navigation in Patients with Cancer: A Feasibility Study. Supportive Care in Cancer, 30, 8173-8182.
https://doi.org/10.1007/s00520-022-07270-5
[40]  Haverfield, M.C., Singer, A.E., Gray, C., Shelley, A., Nash, A. and Lorenz, K.A. (2020) Implementing Routine Communication about Costs of Cancer Treatment: Perspectives of Providers, Patients, and Caregivers. Supportive Care in Cancer, 28, 4255-4262.
https://doi.org/10.1007/s00520-019-05274-2

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133